Showing results (81-90 of 237) with videos related to
Sort By:
Pageof 24
Seminars in Nephrology|May 4, 2024
Epidemiology and Management of Patients With Kidney Disease and Heart Failure With Preserved Ejection FractionMarcelle L Tuttle, James C Fang, Mark J Sarnak, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2024
Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation DevicesMichael Yaoyao Yin, Eleni Maneta, Christos P Kyriakopoulos, et al.Journal of Cardiac Failure|September 30, 2009
Central aortic stiffness is increased in patients with heart failure and preserved ejection fractionAkshay S Desai, Gary F Mitchell, James C Fang, et al.Heart Rhythm|September 19, 2017
Sudden death mechanisms in nonischemic cardiomyopathies: Insights gleaned from clinical implantable cardioverter-defibrillator trialsBenjamin A Steinberg, Siva K Mulpuru, James C Fang, et al.JAMA|December 16, 2004
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trialsAkshay S Desai, James C Fang, William H Maisel, et al.Journal of the American College of Cardiology|August 9, 2020
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert PanelJane E Wilcox, James C Fang, Kenneth B Margulies, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 8, 2021
Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS scoreQussay Marashly, Iosif Taleb, Christos P Kyriakopoulos, et al.Heart Failure Reviews|August 30, 2025
Pharmacological options to relieve congestion in acute heart failureChris J Kapelios, Ali Vazir, Lars H Lund, et al.Archives of Internal Medicine|June 15, 2011
Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trialsIlke Sipahi, Thomas P Carrigan, Douglas Y Rowland, et al.The Lancet. Oncology|June 15, 2010
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trialsIlke Sipahi, Sara M Debanne, Douglas Y Rowland, et al.Pageof 24